Search Results

Meta-analysis of potential biomarkers for predicting clinical efficacy of PD-1/PD-L1 inhibitors in malignancies.

• Authors : LIN Yuhong¹; LIN Zhibing¹; WANG Xiaoxian¹

• Source: Chinese Journal of Immunology. May2024, Vol. 40 Issue 5, p931-938. 8p.

Record details

Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways.

• Authors : Wang, Rong¹ (AUTHOR); He, Shiwei² (AUTHOR); Long, Jun³ (AUTHOR)

• Source: Experimental Hematology & Oncology. 4/23/2024, Vol. 13 Issue 1, p1-30. 30p.

Record details

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.

• Authors : Puyalto, Ander^1,2,3 (AUTHOR); Rodríguez-Remírez, María^1,2,3 (AUTHOR); López, Inés^2,3 (AUTHOR)

• Source: Molecular Cancer. 4/20/2024, Vol. 23 Issue 1, p1-19. 19p.

Record details

CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.

• Authors : Vahidian, Fatemeh^1,2 (AUTHOR) ; Lamaze, Fabien C.¹ (AUTHOR) ; Bouffard, Cédrik^1,2 (AUTHOR)

• Source: Cancers. Feb2024, Vol. 16 Issue 4, p708. 13p.

Record details

Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis.

• Authors : Tan, Jie¹ (AUTHOR); Xue, Qianfei² (AUTHOR); Hu, Xiao¹ (AUTHOR)

• Source: Journal of Translational Medicine. 1/23/2024, Vol. 22 Issue 1, p1-14. 14p.

Record details

Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutations.

• Authors : Ding, Wuwu¹ (AUTHOR); Yang, Pengmin^2,3 (AUTHOR); Zhao, Xiaokai^2,3 (AUTHOR)

• Source: Respiratory Research. 1/18/2024, Vol. 25 Issue 1, p1-11. 11p.

Record details

Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients.

• Authors : Bołkun, Łukasz¹ (AUTHOR) ; Starosz, Aleksandra² (AUTHOR) ; Krętowska-Grunwald, Anna^2,3 (AUTHOR)

• Source: Cancers. Jan2024, Vol. 16 Issue 2, p462. 19p.

Record details

Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes.

• Authors : Wang, Banglu¹ (AUTHOR); Cheng, Daoan¹ (AUTHOR); Ma, Danyu¹ (AUTHOR)

• Source: Cell Communication & Signaling. 1/9/2024, Vol. 22 Issue 1, p1-10. 10p.

Record details

HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway.

• Authors : Konstantopoulos, Georgios¹ (AUTHOR) ; Leventakou, Danai² (AUTHOR) ; Saltiel, Despoina-Rozi¹ (AUTHOR)

Subjects: *GENE expression; *PROGRAMMED cell death 1 receptors; *PROGRAMMED death-ligand 1

• Source: Viruses (1999-4915). Jan2024, Vol. 16 Issue 1, p113. 11p.

Record details

Prognostic value and immunological role of PD-L1 gene in pan-cancer.

• Authors : Wang, Yongfeng^1,2,3,4 (AUTHOR); Jiang, Hong⁵ (AUTHOR); Fu, Liangyin² (AUTHOR)

• Source: BMC Cancer. 1/2/2024, Vol. 24 Issue 1, p1-19. 19p.

Record details